Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS

Journal of Pharmacological and Toxicological Methods

Volumn 59, Issue 3, 2009, Pages 171-180

  Li, Hongyan ^a   Rose, Mark J ^a   Tran, Linh ^a   Zhang, Jingwen ^a   Miranda, Les P ^a   James, Christopher A ^a   Sasu, Barbra J ^a  

^a AMGEN INC   (United States)

Author keywords

Anemia of inflammation; Biomarker; Hepcidin; LC MS MS; Serum

Indexed keywords

BIOLOGICAL MARKER; HEPCIDIN; HEPCIDIN[4-25]; HEPCIDIN[6-25]; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANEMIA; ANIMAL TISSUE; ARTICLE; CALIBRATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; IRON DEFICIENCY; IRON METABOLISM; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RABBIT; SEPSIS;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BIOLOGICAL MARKERS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MASS SPECTROMETRY; RABBITS; SENSITIVITY AND SPECIFICITY;

ORYCTOLAGUS CUNICULUS;

EID: 67349229546     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2009.02.004     Document Type: Article

References (45)

1. Anderson G.J., Frazer D.M., Wilkins S.J., Becker E.M., Millard K.N., Murphy T.L., et al. Relationship between intestinal iron-transporter expression, hepatic hepcidin levels and the control of iron absorption. Biochemical Society Transactions 30 (2002) 724-726
2. Anderson L., and Hunter C.L. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Molecular and Cellular Proteomics 5 (2006) 573-588
3. Andrews N.C. Anemia of inflammation: The cytokine-hepcidin link. Journal of Clinical Investigation 113 (2004) 1251-1253
4. Barany P., vino Filho J.C., and Bergstrom J. High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients. American Journal of Kidney Diseases 29 (1997) 565-568
5. Berna M., Schmalz C., Duffin K., Mitchell P., Chambers M., and Ackermann B. Online immunoaffinity liquid chromatography/tandem mass spectrometry determination of a type II collagen peptide biomarker in rat urine: Investigation of the impact of collision-induced dissociation fluctuation on peptide quantitation. Analytical Biochemistry 356 (2006) 235-243
6. Bertero M.T., and Caligaris-Cappio F. Anemia of chronic disorders in systemic autoimmune diseases. Haematologica 82 (1997) 375-381
7. Bondar O.P., Barnidge D.R., Klee E.W., Davis B.J., and Klee G.G. LC-MS/MS quantification of Zn-a2 glycoprotein: A potential serum biomarker for prostate cancer. Clinical Chemistry (Washington, DC, U.S.) 53 (2007) 673-678
8. Catz P., Shinn W., Kapetanovic I.M., Kim H., Kim M., Jacobson E.L., et al. Simultaneous determination of myristyl nicotinate, nicotinic acid, and nicotinamide in rabbit plasma by liquid chromatography-tandem mass spectrometry using methyl ethyl ketone as a deproteinization solvent. Journal of Chromatography B 829 (2005) 123-135
9. Cooper N., Khosravan R., Erdmann C., Fiene J., and Lee J.W. Quantification of uric acid, xanthine and hypoxanthine in human serum by HPLC for pharmacodynamic studies. Journal of Chromatography B 837 (2006) 1-10
10. FDA. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for industry: Bioanalytical method validation (2001)
11. Fine A. Relevance of C-reactive protein levels in peritoneal dialysis patients. Kidney International 61 (2002) 615-620
12. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 102 (2003) 783-788
13. Ganz T., and Nemeth E. Iron imports. IV. Hepcidin and regulation of body iron metabolism. AJP: Gastrointestinal and Liver Physiology 290 (2006) G199-G203
14. Ganz T., Olbina G., Girelli D., Nemeth E., and Westerman M. Immunoassay for human serum hepcidin. Blood 112 (2008) 4292-4297
15. Gunnell J., Yeun J., Depner T., and Kaysen G. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients. American Journal of Kidney Diseases 33 (1999) 63-72
16. Horl W.H., Jacobs C., Macdougall I.C., Valderrabano F., Parrondo I., Thompson K., et al. European Best Practice Guidelines 14-16: Inadequate response to epoetin. Nephrology Dialysis Transplantation 15 (2000) 43-50
17. Hsu S.P., Chiang C.K., Chien C.T., and Hung K.Y. Plasma prohepcidin positively correlates with hematocrit in chronic hemodialysis patients. Blood Purification 24 (2006) 311-316
18. Inoue K., Garner C., Ackermann B.L., Oe T., and Blair I.A. Liquid chromatography/tandem mass spectrometry characterization of oxidized amyloid beta peptides as potential biomarkers of Alzheimer's disease. Rapid Communications in Mass Spectronometry 20 (2005) 911-918
19. Kay R.G., Gregory B., Grace P.B., and Pleasance S. The application of ultra-performance liquid chromatography/tandem mass spectrometry to the detection and quantitation of apolipoproteins in human serum. Rapid Communications in Mass Spectronometry 21 (2007) 2585-2593
20. Kemna E., Pickkers P., Nemeth E., van der Hoeven H., and Swinkels D. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 106 (2005) 1864-1866
21. Kemna E., Pickkers P., Nemeth E., van der Hoeven H., and Swinkels D. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood 106 (2005) 1864-1866
22. Kindt E., Shum Y., Badura L., Snyder P.J., Brant A., Fountain S., et al. Development and validation of an LC/MS/MS procedure for the quantification of endogenous myo-inositol concentrations in rat brain tissue homogenates. Analytical Chemistry 76 (2004) 4901-4908
23. Kirsch S., Widart J., Louette J., Focant J.F., and De Pauw E. Development of an absolute quantification method targeting growth hormone biomarkers using liquid chromatography coupled to isotope dilution mass spectrometry. Journal of Chromatography A 1153 (2007) 300-306
24. Kobold U., Dulffer T., Dangl M., Escherich A., Kubbies M., Roddiger R., et al. Quantification of hepcidin-25 in human serum by isotope dilution micro-HPLC-tandem mass spectrometry. Clinical Chemistry 54 (2008) 1584-1586
25. Krause A., Neitz S., Magert H.J., Schulz A., Forssmann W.G., Schulz-Knappe P., et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Letters 480 (2000) 147-150
26. Li W., Nemirovskiy O., Fountain S., Mathews W.R., and Szekely-Klepser G. Clinical validation of an immunoaffinity LC-MS/MS assay for the quantification of a collagen type II neoepitope peptide: A biomarker of matrix metalloproteinase activity and osteoarthritis in human urine. Analytical Biochemistry 369 (2007) 41-53
27. Murao N., Ishigai M., Yasuno H., Shimonaka Y., and Yoshinori A. Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up. Rapid Communications in Mass Spectrometry 21 (2007) 4033-4038
28. Murphy A.T., Witcher D.R., Luan P., and Wroblewski V.J. Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry. Blood 110 (2007) 1048-1054
29. Nemeth E., Rivera S., Gabayan V., Keller C., Taudorf S., Pedersen B.K., et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. Journal of Clinical Investigation 113 (2004) 1271-1276
30. Nemeth E., Valore E.V., Territo M., Schiller G., Lichtenstein A., and Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 101 (2003) 2461-2463
31. Nicolas G., Chauvet C., Viatte L., Danan J.L., Bigard X., Devaux I., et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. Journal of Clinical Investigation 110 (2002) 1037-1044
32. Park C.H., Valore E.V., Waring A.J., and Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. Journal of Biological Chemistry 276 (2001) 7806-7810
33. Qureshi A.R., Alvestrand A., Danielsson A., vino-Filho J.C., Gutierrez A., Lindholm B., et al. Factors predicting malnutrition in hemodialysis patients: A cross-sectional study. Kidney International 53 (1998) 773-782
34. Roy C.N., Weinstein D.A., and Andrews N.C. 2002 E. Mead Johnson Award for Research in Pediatrics Lecture: The molecular biology of the anemia of chronic disease: A hypothesis. Pediatric Research 53 (2003) 507-512
35. Roy C.N., Custodio A.O., de Graaf J., Schneider S., Akpan I., Montross L.K., et al. An Hfe-dependent pathway mediates hyposideremia in response to lipopolysaccharide-induced inflammation in mice. Nature Genetics 36 (2004) 481-485
36. Roy C.N., Mak H.H., Akpan I., Losyev G., Zurakowski D., and Andrews N.C. Hepcidin antimicrobial peptide transgenic mice exhibit features of the anemia of inflammation. Blood 109 (2007) 4038-4044
37. Sasu, B.J., Sloan, J., Li, H., Rose, M.J., Dyas, G., Arvedson, T., et al., submitted for publication. Serum Hepcidin but not Prohepcidin may be an Effective Marker for Anemia of Inflammation (AI).
38. Taes Y.E.C., Wuyts B., Boelaert J.R., De Vriese A.S., and Delanghe J.R. Prohepcidin accumulates in renal insufficiency. Clinical Chemistry and Laboratory Medicine 42 (2004) 387-389
39. Tomosugi N., Kawabata H., Wakatabe R., Higuchi M., Yamaya H., Umehara H., et al. Detection of serum hepcidin in renal failure and inflammation by using protein chip system. Blood 108 (2006) 1381-1387
40. Viswanathan C.T., Bansal S., Booth B., DeStefano A.J., Rose M.J., Sailstad J., et al. Quantitative bioanalytical methods validation and implementation: Best practices for chromatographic and ligand binding assays. Pharmaceutical Research 24 (2007) 1962-1973
41. Ward D., Roberts K., Stonelake P., Goon P., Zampronio C., Martin A., et al. SELDI-TOF-MS determination of hepcidin in clinical samples using stable isotope labelled hepcidin as an internal standard. Proteome Science 6 (2008) 28
42. Weinstein D.A., Roy C.N., Fleming M.D., Loda M.F., Wolfsdorf J.I., and Andrews N.C. Inappropriate expression of hepcidin is associated with iron refractory anemia: Implications for the anemia of chronic disease. Blood 100 (2002) 3776-3781
43. Wright M.E., Han D.K., and Aebersold R. Mass spectrometry-based expression profiling of clinical prostate cancer. Molecular and Cellular Proteomics 4 (2005) 545-554
44. Yeun J.Y., Levine R.A., Mantadilok V., and Kaysen G.A. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. American Journal of Kidney Diseases 35 (2000) 469-476
45. Zimmermann J., Herrlinger S., Pruy A., Metzger T., and Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney International 55 (1999) 648-658